Logo

Pharsight, Organon Pen Trial-Modeling Collaboration

Aug 20, 2002

NEW YORK, Aug. 20 - Pharsight today said that Organon will use its clinical trial-modeling -simulation technology to help it develop better clinical trials and improve its drug-development process.

 

The deal, an extension of an existing collaboration, may extend further if both sides are happy with the outcome of this part.

 

Click here for more information.

Breaking News
The Scan

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.